CMET-03. PHASE 1 TRIAL OF OSIMERTINIB WITH STEREOTACTIC RADIOSURGERY IN EGFR MUTANT LUNG CANCER BRAIN METASTASIS

BACKGROUND: Brain metastases (BM) occurs in 25–40% of patients with non-small cell lung cancer (NSCLC). Traditionally patients with brain metastases were treated with whole brain radiation therapy (WBRT), stereotactic radiosurgery (SRS) and surgical resection. Historically, BM is associated with dis...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Thapa, Bicky, Chao, Samuel, Pennell, Nathan, Peereboom, David, Ahluwalia, Manmeet
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216839/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.216
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki